Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Colonic Neoplasms 4Motor Activity 3Colorectal Neoplasms 3Breast Neoplasms 3Rectal Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sarcopenia 1Pancreatitis, Chronic 1Ovarian Neoplasms 1Neoplasms 1Metabolic Syndrome 1Insulin Resistance 1Head and Neck Neoplasms 1Cachexia 1

Interventions

Paclitaxel 177Carboplatin 177Bevacizumab 72Topotecan 55liposomal doxorubicin 54Gemcitabine 53Cisplatin 46Docetaxel 39Cyclophosphamide 37olaparib 32Filgrastim 31pembrolizumab 29Doxorubicin 26niraparib 24Taxes 23Drug Therapy 23Peripheral Blood Stem Cell Transplantation 20Etoposide 17veliparib 15Nivolumab 14sargramostim 13Surveys and Questionnaires 13Immunoglobulin G 13Disulfides 13pazopanib 12Ifosfamide 12Albumin-Bound Paclitaxel 12durvalumab 11atezolizumab 11Trabectedin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Ovarian Neoplasms × Preoperative Exercise × Clear all
NCT05887531 2025-01-29

Abdominopelvic Cancer Prehabilitation

Universitat Jaume I

Phase NA Completed
66 enrolled
GastrointestinalGynecologic

Colonic Neoplasms, Ovarian Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡